This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Asymbescaline" – news · newspapers · books · scholar · JSTOR (August 2019)
Asymbescaline
Names
Preferred IUPAC name
2-(3,4-Diethoxy-5-methoxyphenyl)ethan-1-amine
Other names
3,4-Diethoxy-5-methoxyphenethylamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3 checkY
    Key: VFOAVFQWZYUFQZ-UHFFFAOYSA-N checkY
  • InChI=1/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3
    Key: VFOAVFQWZYUFQZ-UHFFFAOYAI
  • O(c1c(OC)cc(cc1OCC)CCN)CC
Properties
C13H21NO3
Molar mass 239.315 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours.[1] Asymbescaline produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.

See also

References